IperionX Limited — FY2022 Form 20-F Summary
Reporting period: Fiscal year ended June 30, 2022; filed August 26, 2022. The request labels the period “2021 Q4,” but this filing is an annual report for FY2022, not a quarterly filing. Financial statements are in U.S. dollars and prepared under IFRS. The comparative period runs only from July 20, 2020 to June 30, 2021, so it is not a full-year comparison.
Business context
IperionX is an early-stage U.S. critical-minerals and materials developer. Its strategy combines pilot-scale titanium processing technologies, available to the company through agreements and an acquisition option with Blacksand Technology, with the 100%-interest Titan Project in Tennessee. The company had not begun commercial production of titanium or minerals and had no mineral reserves under SEC standards.
Financial performance and liquidity
| Metric | FY2022 | Comparative period |
|---|---|---|
| Revenue | No operating revenue reported | No operating revenue reported |
| Net loss | US$21.5 million | US$13.2 million |
| Operating cash flow | US$(12.1) million | US$(3.6) million |
| Investing cash flow | US$(3.1) million | US$(0.6) million |
| Financing cash flow | US$19.4 million | US$5.8 million |
| Cash and cash equivalents at year-end | US$5.7 million | US$1.7 million |
| Total assets | US$9.9 million | US$2.8 million |
| Total liabilities | US$2.5 million | US$1.0 million |
| Net assets | US$7.4 million | US$1.8 million |
| Loans and borrowings | US$0.5 million | US$0.5 million |
With no commercial revenue, operating margins are not meaningful. The loss increased year over year, driven by higher exploration and evaluation, corporate and administrative, business development, and share-based payment expenses. FY2022 exploration and evaluation expense was US$7.3 million; corporate and administrative expense US$3.1 million; business development expense US$3.2 million; and share-based payment expense US$8.3 million. FY2021 included a US$5.1 million non-cash reverse-acquisition listing expense that did not recur in FY2022.
FY2022 capital expenditures were approximately US$2.8 million. The company funded operations principally through equity issuance, including US$17.6 million from an August 2021 placement and proceeds from option exercises. The filing states that ongoing operations depend on raising additional funding. The auditor highlighted substantial doubt about the company’s ability to continue as a going concern; management considered the going-concern basis appropriate but acknowledged the funding uncertainty.
Material changes and project update
- Exploration and appraisal activity expanded, including drilling, metallurgical testing, engineering work for the Titan Scoping Study, and increased pilot-scale titanium processing in Utah.
- On June 30, 2022, the company reported a Titan Project Scoping Study based on a 25-year mine life. Estimated initial capital cost was US$237 million, including 30% contingency, with an intended accuracy of ±35%; estimated average annual operating cost was about US$67 million, also with ±35% intended accuracy.
- The study’s average annual production targets were 95,500 tonnes of ilmenite, 16,700 tonnes of rutile, 4,600 tonnes of monazite, 22,400 tonnes of premium zircon and 16,000 tonnes of zircon concentrate. These are study targets, not actual production.
- At June 30, 2022, Titan’s reported mineral resource was 431 million metric tons at 2.2% total heavy minerals, containing 9.5 million metric tons of total heavy minerals. It comprised 241 million indicated and 190 million inferred metric tons; there were no measured resources. The company emphasized that it had no SEC-defined reserves.
- Nasdaq trading of the company’s ADSs began June 21, 2022. At fiscal year-end, 140,288,491 ordinary shares were outstanding.
Outlook, risks and unusual items
Management planned further drilling, metallurgical testwork, hydrology and geotechnical work, and economic studies over the following 12 months. It also intended to pursue feasibility work, permits, customer discussions and technology commercialization. The filing gives no firm revenue, earnings or production guidance and states that detailed development plans were not yet in place.
- Funding and going concern: The company has no operating cash inflows other than interest income and expects continuing losses. Further financing is required; equity financing could dilute shareholders. The Titan Project’s estimated US$237 million initial capital requirement substantially exceeds current resources.
- Technology and commercialization: IperionX does not own the technologies and relies on its Blacksand agreements and option. Commercial-scale production, repeatable yields, product quality, customer qualification and offtake remain unproven.
- Blacksand option: The exclusive option to acquire Blacksand was exercisable through December 31, 2022. Exercise would require US$12 million consideration, a US$1 million University of Utah research commitment over three years, and a contingent royalty; funding would be needed.
- Project execution: Titan is at exploration/scoping-study stage, with no reserves. Permitting, land tenure, construction, recovery rates, commodity prices and cost estimates carry material uncertainty.
- Controls: Management concluded disclosure controls were ineffective as of June 30, 2022 and identified material weaknesses involving insufficiently designed and documented controls and inadequate segregation of duties. Remediation was ongoing. No auditor attestation on internal controls was included.
- Other exposure: The filing cites commodity-price, foreign-exchange, environmental, regulatory, supply-chain and personnel risks. The company reported no material operational disruption from the war in Ukraine to date and no material legal proceedings.
- Tax and shareholder matters: IperionX believed it was a passive foreign investment company for FY2022 and expected the same for FY2023, potentially causing adverse U.S. tax consequences. It did not declare dividends and did not anticipate paying them in the foreseeable future.
Most important facts for investors to verify
- Current cash, subsequent financing, cash burn and liquidity runway after June 30, 2022.
- Whether the Blacksand acquisition option was exercised, and the resulting cash, share issuance, royalty and technology-license terms.
- Progress from pilot-scale titanium production toward commercial-scale output, including demonstrated yields, product specifications and customer qualification.
- Updated Titan resource estimates, conversion toward reserves, feasibility-study results, permitting status and revised capital and operating cost estimates.
- Progress and independent validation of remediation of the disclosed material weaknesses in financial reporting controls.
- Current status of the non-binding customer and partnership MOUs; none constituted a binding offtake contract in this filing.